COMMON STOCK PURCHASE WARRANT ARCH THERAPEUTICS, INC.Arch Therapeutics, Inc. • July 8th, 2022 • Surgical & medical instruments & apparatus
Company FiledJuly 8th, 2022 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. (New York City time) on July 6, 2027 (such applicable date, the “Termination Date”) but not thereafter, to subscribe for and purchase from Arch Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 8th, 2022 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJuly 8th, 2022 Company IndustryThis Agreement is made pursuant to the Securities Purchase Agreement, dated as of July 6, 2022 between the Company and each Purchaser (the “Purchase Agreement”).
SECURITY AGREEMENTSecurity Agreement • July 8th, 2022 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • Nevada
Contract Type FiledJuly 8th, 2022 Company Industry JurisdictionTHIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of July 6, 2022 between Arch Therapeutics, Inc., a Nevada corporation (the “Company”), Arch Biosurgery, Inc., a Massachusetts corporation (together with each other Person who becomes a party to this Agreement by execution of a joinder in the form of Exhibit A attached hereto, which shall include all wholly-owned or majority-owned subsidiaries of the Company acquired after the date hereof for so long as this Agreement remains in effect, are hereinafter sometimes referred to individually as a “Debtor” and, collectively, as the “Debtors”) and [***], in its capacity as Collateral Agent for the benefit of itself and each of the Purchasers (as hereinafter defined) (each, together with its respective successors and assigns, a “Secured Party,” and collectively the “Secured Parties”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 8th, 2022 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • Nevada
Contract Type FiledJuly 8th, 2022 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 6, 2022 (the “Effective Date”), by ARCH THERAPEUTICS, INC., a Nevada corporation, with headquarters located at 235 Walnut Street, Suite 6, Framingham, MA 01702 (the “Company”), and each buyer identified on the signature pages hereto (each, including it successors and assigns, a “Buyer” and collectively, the “Buyers”).